Literature DB >> 15494917

Positive predictive value of Gen-Probe APTIMA Combo 2 testing for Neisseria gonorrhoeae in a population of women with low prevalence of N. gonorrhoeae infection.

Matthew R Golden1, James P Hughes, Linda E Cles, Karen Crouse, Katherine Gudgel, Jinxin Hu, Paul D Swenson, Walter E Stamm, H Hunter Handsfield.   

Abstract

We collected specimens from women who tested positive for Neisseria gonorrhoeae using the Gen-Probe APTIMA Combo 2 (AC2), and we performed confirmatory tests using a nucleic acid amplification test (NAAT) that targets alternate gonococcal nucleic acid sequences. Among 59,664 specimens, 280 (0.47%) had positive results using AC2; 265 of these specimens were tested using the confirmatory NAAT, of which 258 yielded positive results (positive predictive value, 97.4%; 95% confidence interval, 95.1%-98.8%). Routine confirmatory testing of specimens with positive AC2 gonorrhea test results is not indicated.

Entities:  

Mesh:

Year:  2004        PMID: 15494917     DOI: 10.1086/424880

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  13 in total

1.  Routine confirmation of positive nucleic acid amplification test results for Neisseria gonorrhoeae is not necessary.

Authors:  Julius Schachter; Max A Chernesky
Journal:  J Clin Microbiol       Date:  2012-01       Impact factor: 5.948

2.  Gonorrhoea.

Authors:  C Bignell; C A Ison; E Jungmann
Journal:  Sex Transm Infect       Date:  2006-12       Impact factor: 3.519

3.  Supplemental testing is still required in australia for samples positive for Neisseria gonorrhoeae by nucleic acid detection tests.

Authors:  G Lum; S M Garland; S Tabrizi; G Harnett; D W Smith; T P Sloots; D M Whiley; J W Tapsall
Journal:  J Clin Microbiol       Date:  2006-11       Impact factor: 5.948

Review 4.  Nucleic acid amplification testing for Neisseria gonorrhoeae: an ongoing challenge.

Authors:  David M Whiley; John W Tapsall; Theo P Sloots
Journal:  J Mol Diagn       Date:  2006-02       Impact factor: 5.568

5.  Evaluation of six commercial nucleic acid amplification tests for detection of Neisseria gonorrhoeae and other Neisseria species.

Authors:  Sepehr N Tabrizi; Magnus Unemo; Athena E Limnios; Tiffany R Hogan; Stig-Ove Hjelmevoll; Susanne M Garland; John Tapsall
Journal:  J Clin Microbiol       Date:  2011-08-03       Impact factor: 5.948

6.  Should Chlamydia trachomatis confirmation make you cross? Performance of collection kits tested across three nucleic acid amplification test platforms.

Authors:  S Scragg; A Bingham; H Mallinson
Journal:  Sex Transm Infect       Date:  2006-08       Impact factor: 3.519

7.  Finding, confirming, and managing gonorrhoea in a population screened for chlamydia using the Gen-Probe Aptima Combo2 assay.

Authors:  S J Lavelle; K E Jones; H Mallinson; A M C Webb
Journal:  Sex Transm Infect       Date:  2006-06       Impact factor: 3.519

8.  Comparison of the Gen-Probe APTIMA Combo 2 assay to the AMPLICOR CT/NG assay for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in urine samples from Australian men and women.

Authors:  Peter Lowe; Peter O'Loughlin; Kathryn Evans; Michael White; Paul B Bartley; Renu Vohra
Journal:  J Clin Microbiol       Date:  2006-07       Impact factor: 5.948

Review 9.  The use of cephalosporins for gonorrhea: the impending problem of resistance.

Authors:  Pennan M Barry; Jeffrey D Klausner
Journal:  Expert Opin Pharmacother       Date:  2009-03       Impact factor: 3.889

10.  Performance of three nucleic acid amplification tests for detection of Chlamydia trachomatis and Neisseria gonorrhoeae by use of self-collected vaginal swabs obtained via an Internet-based screening program.

Authors:  Billie Jo Masek; Nick Arora; Nicole Quinn; Bulbul Aumakhan; Jeff Holden; Andrew Hardick; Patricia Agreda; Mathilda Barnes; Charlotte A Gaydos
Journal:  J Clin Microbiol       Date:  2009-04-22       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.